- conflicts or gaps
- [[{"field": "total_funding_usd", "conflict": "CB Insights reports $11.62M total raised across 7 rounds; PitchBook reports $9.1M raised; Raising.fi reports $0 total funding.", "source_urls": ["https://www.cbinsights.com/company/cb-therapeutics", "https://pitchbook.com/profiles/company/169329-43", "https://raising.fi/company/cbthera"]}, {"field": "series_a_amount", "conflict": "Primary press releases (BusinessWire, FinSMEs) confirm Series A closed May 2021 but do not disclose dollar amount.", "source_urls": ["https://www.businesswire.com/news/home/20210510005112/en/CB-Therapeutics-Closes-on-Oversubscribed-Series-A", "https://www.finsmes.com/2021/05/cb-therapeutics-closes-series-a-funding.html"]}, {"field": "yc_seed_amount", "conflict": "No primary-source confirmation of YC check size for this company; third-party databases list varying seed dates/amounts behind paywalls.", "source_urls": ["https://www.ycombinator.com/companies/cb-therapeutics", "https://www.cbinsights.com/company/cb-therapeutics/financials"]}, {"field": "headquarters_location", "conflict": "YC lists San Diego, CA; company press and CB Insights list Carlsbad, CA (San Diego metro). Both are consistent at regional level.", "source_urls": ["https://yc-oss.github.io/api/batches/summer-2018/cb-therapeutics.json", "https://www.cbinsights.com/company/cb-therapeutics"]}, {"field": "employee_count", "conflict": "YC profile lists team_size=18; company team page lists 14 named non-founder staff plus 2 co-founders; no current official headcount published on website.", "source_urls": ["https://yc-oss.github.io/api/batches/summer-2018/cb-therapeutics.json", "https://www.cbthera.com/team"]}, {"field": "founded_year_vs_ops_claim", "conflict": "Third-party sources cite founded 2015; company homepage claims '12 years of continuous ops' (implies ~2014 if measured in 2026).", "source_urls": ["https://www.cbinsights.com/company/cb-therapeutics", "https://www.cbthera.com/"]}, {"field": "patent_count", "conflict": "Company site claims 8 granted US patents; CB Insights reports 22 patents filed.", "source_urls": ["https://www.cbthera.com/", "https://www.cbinsights.com/company/cb-therapeutics"]}, {"field": "founder_name", "conflict": "YC uses 'Sher Butt'; press releases and team page use 'Sher Ali Butt'.", "source_urls": ["https://www.ycombinator.com/companies/cb-therapeutics", "https://www.cbthera.com/team"]}, {"field": "cleveland_clinic_partnership", "conflict": "April 2020 Cleveland Clinic MOU reported by secondary source; no recent company press confirming active clinical trials or ongoing collaboration.", "source_urls": ["https://psychedelicreview.com/organization/cb-therapeutics/"]}, {"field": "investor_list_completeness", "conflict": "CB Insights states 7 investors but only names 5 publicly; full cap table not disclosed in accessible primary sources.", "source_urls": ["https://www.cbinsights.com/company/cb-therapeutics"]}]]
- source urls
- ["https://ir.atai.life/news-releases/news-release-details/atai-life-sciences-launches-tryptagenix-further-expand-atais", "https://pitchbook.com/profiles/company/169329-43", "https://psychedelicreview.com/organization/cb-therapeutics/", "https://raising.fi/company/cbthera", "https://techcrunch.com/2018/09/06/cb-therapeutics-lab-grown-cannabinoids-could-unlock-new-medicines-and-make-others-affordable/", "https://www.businesswire.com/news/home/20210510005112/en/CB-Therapeutics-Closes-on-Oversubscribed-Series-A", "https://www.cbinsights.com/company/cb-therapeutics", "https://www.cbinsights.com/company/cb-therapeutics/financials", "https://www.cbthera.com/", "https://www.cbthera.com/brands", "https://www.cbthera.com/team", "https://www.finsmes.com/2021/05/cb-therapeutics-closes-series-a-funding.html", "https://www.globenewswire.com/news-release/2021/12/09/2349577/0/en/CB-Therapeutics-and-atai-Life-Sciences-launch-TryptageniX-to-sustainably-supply-and-develop-clinically-relevant-compounds-to-tackle-the-growing-mental-health-crisis.html", "https://www.ycombinator.com/companies/cb-therapeutics", "https://yc-oss.github.io/api/batches/summer-2018/cb-therapeutics.json"]